EMA Authorised: Memantine ratiopharm (memantine hydrochloride) — Ratiopharm GmbH

View source ↗

Summary

Memantine ratiopharm has been authorised for use in its indicated therapeutic area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine ratiopharm (memantine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: Ratiopharm GmbH. Decision date: 03/06/2022